Cigna Corporation

(New York Stock Exchange)
Back to all articles
Bullish +75

Cigna launches Health Sense: Piper targets Cigna Group stock at USD 370

Company update Product launch AI-generated analysis

πŸš€ Cigna Group launches Health Sense, a personalized care model targeting a 10% reduction in inefficient healthcare spending by 2030.

πŸ’° Second-quarter 2026 revenue reached USD 71.7 billion, up 7% year-over-year, with adjusted EPS of USD 7.78.

πŸ“ˆ Specialty and Care Services delivered 22% year-over-year growth in pre-tax adjusted earnings to USD 1.1 billion.

πŸ₯ Cigna Healthcare revenue grew 10% year over year to USD 11.8 billion, supporting the new initiative.

🎯 Management raised full-year 2026 adjusted EPS guidance to at least USD 30.45 and set a 10-14% growth target through 2030.

πŸ“… Health Sense will initially focus on oncology and cardiometabolic conditions starting in early 2027.

πŸ“Š Market capitalization is approximately USD 67.9 billion with the stock trading near EUR 258.70.

πŸ—“οΈ Third-quarter results are scheduled for release on November 5, 2026, followed by an earnings conference call.

πŸ‘ Analyst Piper Sandler maintains a target price of USD 370 for Cigna Group stock.

Bullish Signals
  • Cigna Group launched Health Sense, a personalized care model projected to reduce inefficient healthcare spending by 10% by 2030.
  • Second-quarter 2026 revenue rose 7% year-over-year to USD 71.7 billion, demonstrating strong top-line growth.
  • Adjusted earnings per share reached USD 7.78 in Q2 2026, reflecting improved profitability.
  • Specialty and Care Services delivered a robust 22% year-over-year increase in pre-tax adjusted earnings to USD 1.1 billion.
  • Cigna Healthcare revenue grew 10% year over year to USD 11.8 billion, validating the core business model.
  • Management raised full-year 2026 adjusted EPS guidance to at least USD 30.45, signaling confidence in execution.
  • The company set a long-term target of 10% to 14% adjusted earnings per share growth through 2030.
Full Analysis
Cigna Group has launched Health Sense, a personalized care model designed to reduce inefficient healthcare spending by 10% by 2030. The initiative, which targets oncology and cardiometabolic conditions, is scheduled to begin operations in early 2027. This strategic launch follows strong financial performance in the second quarter of 2026, providing a solid revenue base for the new program. Second-quarter 2026 results showed total revenue reaching USD 71.7 billion, representing a 7% increase year-over-year. Adjusted earnings per share climbed to USD 7.78, driven by significant growth in Specialty and Care Services, which saw pre-tax adjusted earnings rise 22% to USD 1.1 billion. Cigna Healthcare revenue specifically grew 10% to USD 11.8 billion. Management has raised its full-year 2026 adjusted earnings per share guidance to at least USD 30.45 and reaffirmed a long-term target of 10% to 14% annual growth through 2030. The company is set to release third-quarter results on November 5, 2026, with the Health Sense launch marking a concrete operational benchmark for its future strategy. Analyst Piper Sandler has maintained a target price of USD 370 for Cigna Group stock. The market capitalization stands at approximately USD 67.9 billion as of mid-October 2026. Investors are closely watching the execution of Health Sense to validate the company's broader model and margin expansion capabilities.